The female runner: Gender specifics

Clinics in Sports Medicine

Volumn 29, Issue 3, 2010, Pages 477-498

  Lynch, Stacy L ^a   Hoch, Anne Z ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Exercise and pregnancy; Female athlete triad; Female runner; Gender specifics; Stress incontinence

Indexed keywords

FOLIC ACID;

AMENORRHEA; ATHLETE; BIOMECHANICS; BODY COMPOSITION; BONE DENSITY; BONE MINERAL; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIET SUPPLEMENTATION; EATING DISORDER; EXERCISE; FEMALE; FEMALE ATHLETE TRIAD; HEART RATE; HUMAN; MENSTRUATION DISORDER; NEURAL TUBE DEFECT; OSTEOARTHRITIS; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RUNNING; SCREENING TEST; SEX DIFFERENCE; SPORT; STRESS INCONTINENCE; URINE INCONTINENCE; VASCULAR ENDOTHELIUM;

ATHLETIC INJURIES; BODY COMPOSITION; BONE DENSITY; FEMALE; FEMALE ATHLETE TRIAD SYNDROME; HEALTH STATUS; HUMANS; MALE; PREGNANCY; RISK FACTORS; RUNNING; SEX CHARACTERISTICS; SEX FACTORS; UNITED STATES; URINARY INCONTINENCE, STRESS; WOMEN'S HEALTH;

EID: 77953760869     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2010.03.003     Document Type: Review

References (174)

1. US Department of Labor Title IX, Education amendments of 1972 Available at:, Accessed June 5, 2009. http://www.dol.gov/oasam/regs/statutes/titleIX.htm.
2. NFSHSA 2005-06 High School Athletics Participation Survey: based on competition at the high school level in 2005-06 school year. National Federation of State High Schools 2006, The National Federation of States High Schools Association Handbook, Kansas City (MO).
3. Gender equity in intercollegiate athletics: a practical guide for colleges and universities - 2008 2008, National Collegiate Athletic Association, Indianapolis (IN), Available at:, Accessed June 15, 2009. http://www.ncaapublications.com/p-4023-gender-equity-in-intercollegiate-athletics-2008.aspx.
4. Lopiano D. Gender equity in sports. Medical and orthopedic issues of active and athletic women 1994, 13-22. Hanley & Belfus, Philadelphia. R. Agostini (Ed.).
5. Burton N.M. The stronger women get, the more men love football: sexism and the American culture of sports 2005, Dare Press, Arlington (VA).
6. Thomas K. A city team's struggle shows disparity in girls' sports 2009. Available at:, Accessed June 15, 2009. http://www.nytimes.com/2009/06/14/sports/14girls.html?_r=3&th&emc=th.
7. Beijing Organizing Committee for the Games of the XXIX Olympiad Official website of the Beijing 2008 Olympic Games: record women's participation Available at:, Accessed June 19, 2009. http://en.beijing2008.cn/news/official/ioc/n214559789.shtml.
8. United States Olympic Committee 2008 United States Olympic Team entered into XXVIV Olympic Games in Beijing, China 2008. Available at:, Accessed June 19, 2009. http://teamusa.org/news/article/2744.
9. NBC Universal Team USA: track and field - women Available at:, Accessed June 19, 2009. http://www.nbcolympics.com/teamusa/meettheteam/newsid=114076.html.
10. NBC Universal Team USA: track and field - men Available at:, Accessed June 19, 2009. http://www.nbcolympics.com/teamusa/meettheteam/newsid=114075.html#track+field+men.
11. United States Olympic Committee Competition information: metal standings - athletics 2008. Available at:, Accessed June 19, 2009. http://results.beijing2008.cn/WRM/ENG/INF/AT/C95/AT0000000.shtml.
12. MarketResearch.com The U.S. market for women's athletic apparel 2001. Available at:, Accessed June 12, 2009. http://www.marketresearch.com/product/display.asp=productid=186555&xs=r.
13. Van Riper T., Badenhausen K. Top earning female athletes 2008. Available at:, Accessed June 30, 3009. http://www.forbes.com/2008/07/22/women-athletes-endorsements-biz-sports-cx_tvr_kb_0722athletes.html.
14. Taimela S., Kujala U.M., Osterman K. Intrinsic risk factors and athletic injuries. Sports Med 1990, 9(4):205-215.
15. Greydanus D.E., Patel D.R. The female athlete. Before and beyond puberty. Pediatr Clin North Am 2002, 49(3):553-580.
16. Hewett T.E., Myer G.D., Ford K.R. Decrease in neuromuscular control about the knee with maturation in female athletes. J Bone Joint Surg Am 2004, 86(8):1601-1608.
17. Bailey D.A., Martin A.D., McKay H.A., et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res 2000, 15(11):2245-2250.
18. Natural Hormones About testosterone Available at:, Accessed August 7, 2009. http://www.natural-hormones.net/testosterone-about.htm.
19. Cureton K.J., Collins M.A., Hill D.W., et al. Muscle hypertrophy in men and women. Med Sci Sports Exerc 1988, 20(4):338-344.
20. Ebben W., Jensen R. Strength training in women: debunking myths that block opportunity. Phys Sportsmed 1998, 26:86-97.
21. Huston L.J., Wojtys E.M. Neuromuscular performance characteristics in elite female athletes. Am J Sports Med 1996, 24(4):427-436.
22. Yurko-Griffin L., Harris S. Female athletes. Care of the young athlete 1999, 137-148. American Academy of Orthopaedic Surgeons, Rosemont (IL). J. Sullivan, S. Anderson (Eds.).
23. Malina R.M. Body composition in athletes: assessment and estimated fatness. Clin Sports Med 2007, 26(1):37-68.
24. Noakes T.D. The lore of running 1991, Leisure Press, Champaign (IL).
25. Wells C. Women, sport and performance: a physiological perspective 1991, Human Kinetics, Champaign (IL), p. 3-34.
26. Torstveit M.K., Sundgot-Borgen J. Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: a comprehensive controlled study. Br J Sports Med 2005, 39(5):282-287.
27. Hoch A.Z., Pajewski N.M., Moraski L., et al. Prevalence of the female athlete triad in high school athletes and sedentary students. Clin J Sport Med 2009, 19(5):421-428.
28. Kannus P., Haapasalo H., Sankelo M., et al. Effect of starting age of physical activity on bone mass in the dominant arm of tennis and squash players. Ann Intern Med 1995, 123(1):27-31.
29. Duncan C.S., Blimkie C.J., Cowell C.T., et al. Bone mineral density in adolescent female athletes: relationship to exercise type and muscle strength. Med Sci Sports Exerc 2002, 34(2):286-294.
30. Lloyd T., Chinchilli V.M., Eggli D.F., et al. Body composition development of adolescent white females: the Penn State Young Women's Health Study. Arch Pediatr Adolesc Med 1998, 152(10):998-1002.
31. Tanner J. Growth at adolescence 1962, Blackwell Publishers Ltd, Oxford.
32. Hale R. Factors important to women engaged in regular physical activity. Sports medicine and physiology 1984, 250-269. WB Saunders, Philadelphia. R. Strauss (Ed.).
33. Marshall J. Myths about women's sports. The sports doctor's fitness book for women 1981, 6-13. Delacorte, New York. J. Marshall (Ed.).
34. Astrand P., Rodahl K. Textbook of work physiology: physiological bases of exercise 1977, McGraw-Hill, New York.
35. DeVries H. Physiology of exercise for physical education and athletics 1980, WC Brown Co, Dubuque (IA).
36. Guenette J.A., Witt J.D., McKenzie D.C., et al. Respiratory mechanics during exercise in endurance-trained men and women. J Physiol 2007, 581(Pt 3):1309-1322.
37. Cureton K.J., Sparling P.B. Distance running performance and metabolic responses to running in men and women with excess weight experimentally equated. Med Sci Sports Exerc 1980, 12(4):288-294.
38. Cureton K., Bishop P., Hutchinson P., et al. Sex difference in maximal oxygen uptake. Effect of equating haemoglobin concentration. Eur J Appl Physiol Occup Physiol 1986, 54(6):656-660.
39. Prather H., Hunt D. Issues unique to the female runner. Phys Med Rehabil Clin N Am 2005, 16(3):691-709.
40. Shultz S.J., Perrin D.H. Using surface electromyography to assess sex differences in neuromuscular response characteristics. J Athl Train 1999, 34(2):165-176.
41. Rozzi S.L., Lephart S.M., Gear W.S., et al. Knee joint laxity and neuromuscular characteristics of male and female soccer and basketball players. Am J Sports Med 1999, 27(3):312-319.
42. Dugan S.A. Sports-related knee injuries in female athletes: what gives?. Am J Phys Med Rehabil 2005, 84(2):122-130.
43. Arnheim D. Modern principles of athletic training 1989, Mosby, St. Louis (MO).
44. Thomas C. Factors important to women participants in vigorous athletics. Sports medicine and physiology 1979, 304-319. WB Saunders, Philadelphia. R. Strauss (Ed.).
45. Atwater A. Biomechanics and the female athlete. Sports science perspectives for women 1988, 1-12. Human Kinetics, Champaign (IL). J. Puhl, C. Brown, R. Voy (Eds.).
46. Klafs C., Lyon M. The female athlete: a coach's guide to conditioning and training 1978, CV Mosby Co, St. Louis (MO), p. 15-46.
47. Ireland M.L., Willson J.D., Ballantyne B.T., et al. Hip strength in females with and without patellofemoral pain. J Orthop Sports Phys Ther 2003, 33(11):671-676.
48. Ferber R., Hreljac A., Kendall S. Suspected mechanism in the cause of overuse running injuries: a clinical review. Sports Health: A Multidisciplinary Approach 2009, 1(3):242-246. Available at: http://sph.sagepub.com/. Accessed March 5, 2010.
49. Horton M., Hall T. Quadriceps femoris muscle angle: normal values and relationships with gender and selected skeletal measures. Phys Ther 1989, 69:897-901.
50. Fredericson M., Cookingham C.L., Chaudhari A.M., et al. Hip abductor weakness in distance runners with iliotibial band syndrome. Clin J Sport Med 2000, 10(3):169-175.
51. Earl J., Hoch A.Z., Labisch T., et al. Patient outcomes, strength and lower extremity biomechanics following a proximal rehabilitation program in women with patellofemoral pain syndrome. J Athl Train 2008, 43(3):S51.
52. Landry S.C., McKean K.A., Hubley-Kozey C.L., et al. Neuromuscular and lower limb biomechanical differences exist between male and female elite adolescent soccer players during an unanticipated run and crosscut maneuver. Am J Sports Med 2007, 35(11):1901-1911.
53. Davidson D., Welborn T., Azure D., et al. Male and female body shape preferences of young children in the United States, Main Land China and Turkey. Child Study 2002, 32(3):131-133.
54. McCabe M.P., Ricciardelli L.A. A prospective study of pressures from parents, peers, and the media on extreme weight change behaviors among adolescent boys and girls. Behav Res Ther 2005, 43(5):653-668.
55. Phares V., Steinberg A., Thompson K. Gender differences in peer and parental influences: body image disturbances, self-worth and psychological functioning in preadolescent children. J Youth Adolesc 2004, 33(5):421-429.
56. Schur E.A., Sanders M., Steiner H. Body dissatisfaction and dieting in young children. Int J Eat Disord 2000, 27(1):74-82.
57. Sundgot-Borgen J. Risk and trigger factors for the development of eating disorders in female elite athletes. Med Sci Sports Exerc 1994, 26(4):414-419.
58. Zhang J., Savitz D.A. Exercise during pregnancy among US women. Ann Epidemiol 1996, 6(1):53-59.
59. Clapp J.F. Long-term outcome after exercising throughout pregnancy: fitness and cardiovascular risk. Am J Obstet Gynecol 2008, 199(5):489.
60. Symons Downs D., Hausenblas H.A. Women's exercise beliefs and behaviors during their pregnancy and postpartum. J Midwifery Womens Health 2004, 49(2):138-144.
61. Hale R.W., Milne L. The elite athlete and exercise in pregnancy. Semin Perinatol 1996, 20(4):277-284.
62. Lof M., Forsum E. Activity pattern and energy expenditure due to physical activity before and during pregnancy in healthy Swedish women. Br J Nutr 2006, 95(2):296-302.
63. ACOG Committee Obstetric Practice ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period. Obstet Gynecol 2002, 99(1):171-173.
64. Holschen J.C. The female athlete. South Med J 2004, 97(9):852-858.
65. Clapp J.F., Kim H., Burciu B., et al. Continuing regular exercise during pregnancy: effect of exercise volume on fetoplacental growth. Am J Obstet Gynecol 2002, 186(1):142-147.
66. Bergmann A., Zygmunt M., Clapp J.F. Running throughout pregnancy: effect on placental villous vascular volume and cell proliferation. Placenta 2004, 25(8-9):694-698.
67. Kardel K.R., Kase T. Training in pregnant women: effects on fetal development and birth. Am J Obstet Gynecol 1998, 178(2):280-286.
68. Clapp J.F., Simonian S., Lopez B., et al. The one-year morphometric and neurodevelopmental outcome of the offspring of women who continued to exercise regularly throughout pregnancy. Am J Obstet Gynecol 1998, 178(3):594-599.
69. Beilock S.L., Feltz D.L., Pivarnik J.M. Training patterns of athletes during pregnancy and postpartum. Res Q Exerc Sport 2001, 72(1):39-46.
70. Clapp J.F., Capeless E. The VO2max of recreational athletes before and after pregnancy. Med Sci Sports Exerc 1991, 23(10):1128-1133.
71. Artal R., O'Toole M. Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. Br J Sports Med 2003, 37(1):6-12.
72. Milsom I., Abrams P., Cardozo L., et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001, 87(9):760-766.
73. Hannestad Y.S., Rortveit G., Sandvik H., et al. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000, 53(11):1150-1157.
74. Bo K., Borgen J.S. Prevalence of stress and urge urinary incontinence in elite athletes and controls. Med Sci Sports Exerc 2001, 33(11):1797-1802.
75. Zhu L., Lang J., Wang H., et al. The prevalence of and potential risk factors for female urinary incontinence in Beijing, China. Menopause 2008, 15(3):566-569.
76. Crepin G., Biserte J., Cosson M., et al. The female urogenital system and high level sports. Bull Acad Natl Med 2006, 190(7):1479-1491.
77. Warren M.P., Shantha S. The female athlete. Baillieres Best Pract Res Clin Endocrinol Metab 2000, 14(1):37-53.
78. Carls C. The prevalence of stress urinary incontinence in high school and college-age female athletes in the midwest: implications for education and prevention. Urol Nurs 2007, 27(1):21-24. 39.
79. Nygaard I.E., Thompson F.L., Svengalis S.L., et al. Urinary incontinence in elite nulliparous athletes. Obstet Gynecol 1994, 84(2):183-187.
80. Nygaard I.E. Does prolonged high-impact activity contribute to later urinary incontinence? A retrospective cohort study of female Olympians. Obstet Gynecol 1997, 90(5):718-722.
81. Mayo Foundation Urinary incontinence 2009. Available at:, Accessed July 27, 2009. http://www.mayoclinic.com/health/urinary-incontinence/DS00404/DSECTION=treatments-and-drugs.
82. Helmick C.G., Felson D.T., Lawrence R.C., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008, 58(1):15-25.
83. Lawrence R.C., Helmick C.G., Arnett F.C., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41(5):778-799.
84. Arthritis Foundation News from the Arthritis Foundation: osteoarthritis fact sheet Available at:, Accessed July 27, 2009. http://www.arthritis.org/media/newsroom/media-kits/Osteoarthritis_fact_sheet.pdf.
85. Felson D.T., Niu J., Clancy M., et al. Effect of recreational physical activities on the development of knee osteoarthritis in older adults of different weights: the Framingham Study. Arthritis Rheum 2007, 57(1):6-12.
86. Felson D.T., Zhang Y., Anthony J.M., et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 1992, 116(7):535-539.
87. Nattiv A., Loucks A.B., Manore M.M., et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007, 39(10):1867-1882.
88. Sundgot-Borgen J. Nutrient intake of female elite athletes suffering from eating disorders. Int J Sport Nutr 1993, 3(4):431-442.
89. Wade G.N., Schneider J.E., Li H.Y. Control of fertility by metabolic cues. Am J Physiol 1996, 270(1 Pt 1):E1-19.
90. Kaiserauer S., Snyder A.C., Sleeper M., et al. Nutritional, physiological, and menstrual status of distance runners. Med Sci Sports Exerc 1989, 21(2):120-125.
91. Marcus R., Cann C., Madvig P., et al. Menstrual function and bone mass in elite women distance runners. Endocrine and metabolic features. Ann Intern Med 1985, 102(2):158-163.
92. Practice Committee of the American Society for Reproductive Medicine Current evaluation of amenorrhea. Fertil Steril 2004, 82(1):266-272.
93. De Souza M.J., Williams N.I. Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum Reprod Update 2004, 10(5):433-448.
94. Loucks A.B., Thuma J.R. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003, 88(1):297-311.
95. Golden N.H., Carlson J.L. The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci 2008, 113:5163-5178.
96. Meczekalski B., Podfigurna-Stopa A., Warenik-Szymankiewicz A., et al. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol 2008, 24(1):4-11.
97. Rigotti N.A., Nussbaum S.R., Herzog D.B., et al. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984, 311(25):1601-1606.
98. Drinkwater B.L., Bruemner B., Chesnut C.H. Menstrual history as a determinant of current bone density in young athletes. JAMA 1990, 263(4):545-548.
99. Robinson T.L., Snow-Harter C., Taaffe D.R., et al. Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J Bone Miner Res 1995, 10(1):26-35.
100. Risser W.L., Lee E.J., LeBlanc A., et al. Bone density in eumenorrheic female college athletes. Med Sci Sports Exerc 1990, 22(5):570-574.
101. Weaver C.M. The role of nutrition on optimizing peak bone mass. Asia Pac J Clin Nutr 2008, 17(Suppl):1135-1137.
102. Ihle R., Loucks A.B. Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res 2004, 19(8):1231-1240.
103. Khan K., McKay H., Kannus P., et al. Physical activity and bone health 2001, Human Kinetics, Champaign (IL).
104. Hoch A.Z., Stavrakos J.E., Schimke J.E. Prevalence of female athlete triad characteristics in club triathlon team. Arch Phys Med Rehabil 2007, 88(5):681-682.
105. Thompson S.H. Characteristics of the female athlete triad in collegiate cross-country runners. J Am Coll Health 2007, 56(2):129-136.
106. Torstveit M.K., Rosenvinge J.H., Sundgot-Borgen J. Prevalence of eating disorders and the predictive power of risk models in female elite athletes: a controlled study. Scand J Med Sci Sports 2008, 18(1):108-118.
107. Dusek T. Influence of high intensity training on menstrual cycle disorders in athletes. Croat Med J 2001, 42(1):79-82.
108. Nichols J.F., Rauh M.J., Lawson M.J., et al. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med 2006, 160(2):137-142.
109. Wiksten-Almstromer M., Hirschberg A.L., Hagenfeldt K. Reduced bone mineral density in adult women diagnosed with menstrual disorders during adolescence. Acta Obstet Gynecol Scand 2009, 88(5):543-549.
110. Beals K.A., Hill A.K. The prevalence of disordered eating, menstrual dysfunction, and low bone mineral density among US collegiate athletes. Int J Sport Nutr Exerc Metab 2006, 16(1):1-23.
111. Torstveit M.K., Sundgot-Borgen J. The female athlete triad exists in both elite athletes and controls. Med Sci Sports Exerc 2005, 37(9):1449-1459.
112. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA 1991, 265(14):1861-1867.
113. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994, 121:936-941.
114. Mijatovic V., Kenemans P., Jakobs C., et al. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998, 91(3):432-436.
115. Moreau K.L., Donato A.J., Tanaka H., et al. Basal leg blood flow in healthy women is related to age and hormone replacement therapy status. J Physiol 2003, 547(Pt 1):309-316.
116. Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(12):836-843.
117. Rosenson R.S., Tangney C.C., Mosca L.J. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women. Arterioscler Thromb Vasc Biol 1998, 18(12):1902-1905.
118. Stevenson J.C., Crook D., Godsland I.F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993, 98(1):83-90.
119. Yen C.H., Hsieh C.C., Chou S.Y., et al. 17Beta-estradiol inhibits oxidized low density lipoprotein-induced generation of reactive oxygen species in endothelial cells. Life Sci 2001, 70(4):403-413.
120. Yildirir A., Aybar F., Tokgozoglu L., et al. Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. Gynecol Obstet Invest 2002, 53(1):54-58.
121. Hoch A.Z., Dempsey R.L., Carrera G.F., et al. Is there an association between athletic amenorrhea and endothelial cell dysfunction?. Med Sci Sports Exerc 2003, 35(3):377-383.
122. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., et al. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab 2005, 90(6):3162-3167.
123. Walsh B.W., Schiff I., Rosner B., et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991, 325(17):1196-1204.
124. Bush T.L., Barrett-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987, 75(6):1102-1109.
125. Cid M.C., Schnaper H.W., Kleinman H.K. Estrogens and the vascular endothelium. Ann N Y Acad Sci 2002, 966:143-157.
126. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002, 89(12A):12E-17E.
127. Schnaper H.W., McGuire J., Runyan C., et al. Sex steroids and the endothelium. Curr Med Chem 2000, 7(5):519-531.
128. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
129. Dusting G.J., Fennessy P., Yin Z.L., et al. Nitric oxide in atherosclerosis: vascular protector or villain?. Clin Exp Pharmacol Physiol Suppl 1998, 25:S34-S41.
130. Perregaux D., Chaudhuri A., Mohanty P., et al. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 1999, 48(2):227-232.
131. Celermajer D.S. Endothelial dysfunction: does it matter? Is it reversible?. J Am Coll Cardiol 1997, 30:325-333.
132. Ganz P., Vita J.A. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 2003, 108(17):2049-2053.
133. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340(2):115-126.
134. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease. Circulation 2000, 101(16):1899-1906.
135. Ohmichi M., Kanda Y., Hisamoto K., et al. Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas 2003, 44(2):125-131.
136. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
137. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., et al. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab 2005, 90(3):1354-1359.
138. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340(8828):1111-1115.
139. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
140. Heiss G., Wallace R., Anderson G.L., et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008, 299(9):1036-1045.
141. Schutte A.E., Huisman H.W., Oosthuizen W., et al. Cardiovascular effects of oral supplementation of vitamin C, E and folic acid in young healthy males. Int J Vitam Nutr Res 2004, 74(4):285-293.
142. Mangoni A.A., Sherwood R.A., Swift C.G., et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 2002, 252(6):497-503.
143. van Dijk R.A., Rauwerda J.A., Steyn M., et al. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001, 21(12):2072-2079.
144. Chambers J.C., Ueland P.M., Obeid O.A., et al. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000, 102(20):2479-2483.
145. Mangoni A.A., Sherwood R.A., Asonganyi B., et al. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens 2005, 18(2 Pt 1):220-226.
146. Mangoni A.A., Ouldred E., Swif C.G., et al. Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease. J Am Geriatr Soc 2001, 49(7):1003-1004.
147. Deol P.S., Barnes T.A., Dampier K., et al. The effects of folic acid supplements on coagulation status in pregnancy. Br J Haematol 2004, 127(2):204-208.
148. Undas A., Domagala T.B., Jankowski M., et al. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res 1999, 95(6):281-288.
149. Mangoni A.A., Arya R., Ford E., et al. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res 2003, 110(1):13-17.
150. Verhaar M.C., Wever R.M., Kastelein J.J., et al. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998, 97(3):237-241.
151. Verhaar M.C., Wever R.M., Kastelein J.J., et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: a randomized placebo-controlled trial. Circulation 1999, 100:335-338.
152. van Etten R.W., de Koning E.J., Verhaar M.C., et al. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002, 45(7):1004-1010.
153. Doshi S.N., McDowell I.F., Moat S.J., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler Thromb Vasc Biol 2001, 21(7):1196-1202.
154. Doshi S.N., McDowell I.F., Moat S.J., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002, 105(1):22-26.
155. Birnbacher R., Messerschmidt A.M., Pollak A.P. Diagnosis and prevention of neural tube defects. Curr Opin Urol 2002, 12(6):461-464.
156. Maxwell A.J., Anderson B.E., Cooke J.P. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med 2000, 5(1):11-19.
157. Boger R.H., Bode-Boger S.M., Thiele W., et al. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 1998, 32(5):1336-1344.
158. Lekakis J.P., Papathanassiou S., Papaioannou T.G., et al. Oral L-arginine improves endothelial dysfunction in patients with essential hypertension. Int J Cardiol 2002, 86(2-3):317-323.
159. Hambrecht R., Hilbrich L., Erbs S., et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000, 35(3):706-713.
160. Wilmink H.W., Stroes E.S., Erkelens W.D., et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 2000, 20(1):185-188.
161. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23(2):168-175.
162. Wever R.M., van Dam T., van Rijn H.J., et al. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 1997, 237(2):340-344.
163. Pancharuniti N., Lewis C.A., Sauberlich H.E., et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994, 59(4):940-948.
164. van den B.M., Boers G.H., Franken D.G., et al. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 1995, 25(3):176-181.
165. Hoch A.Z., Pajewski N.M., Hoffmann R.G., et al. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. J Sports Sci Med 2009, 81:23-29.
166. Hoch A.Z., Lynch S.L., Jurva J.W., et al. Folic acid supplementation improves vascular function in amenorrheic runners. Clin J Sport Med 2010, 20(3):205-210.
167. Hathcock J.N. Vitamins and minerals: efficacy and safety. Am J Clin Nutr 1997, 66(2):427-437.
168. Moens A.L., Claeys M.J., Wuyts F.L., et al. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2007, 99(4):476-481.
169. Title L.M., Ur E., Giddens K., et al. Folic acid improves endothelial dysfunction in type 2 diabetes-an effect independent of homocysteine-lowering. Vasc Med 2006, 11(2):101-109.
170. Woo K.S., Chook P., Lolin Y.I., et al. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999, 34(7):2002-2006.
171. US Food and Drug Administration The FDA Safety Information and Adverse Event Reporting Program: medical product safety information Available at:, Accessed December 8, 2008. http://www.fda.gov/medwatch/SAFETY.htm.
172. Herbert V. Folic acid. Modern nutrition in health and disease 1999, 433-466. Williams & Wilkins, Baltimore (MD). M. Shils, J. Olson, M. Shike (Eds.).
173. National Institutes of Health Dietary supplement fact sheet: folate 2007. Available at:, Accessed June 12, 2009. http://ods.od.nih.gov/factsheets/folate.asp.
174. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007, 297(21):2351-2359.